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Abstract 
 
A survey was conducted between 3 August and 5 October 2011 to test and evaluate 
the knowledge and attitudes of the military and civilian medical practitioners at the 
royal medical Service in the kingdom of Bahrain with regards to the clinical 
application of hyperbaric oxygen therapy. The survey consisted of a questionnaire 
and a semi-structured interview in which a total of 93 (out of a possible 302) medical 
practitioners were included (13 participated in the interviews).   
Similar to findings of previous studies, the knowledge of medical practitioners in 
Bahrain regarding hyperbaric oxygen therapy was low.  Several practitioners were 
able to mention at least one indication for the therapy.  No single factor had a 
statistically significant association with knowledge or the lack thereof.  A large 
proportion of the participants had a positive attitude towards the use of hyperbaric 
oxygen therapy, felt that it is a valid treatment modality and they would refer their 
patients for such treatment.  They would like to receive more information on 
hyperbaric oxygen therapy. 
Educational interventions to address the knowledge gap would likely be effective, 
since most participants have a positive attitude towards the therapy and believe that 
it is cost-effective. 
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Introduction 
 
Although strong evidence has been growing recently to support the application of 
hyperbaric oxygen therapy (HBOT) in the treatment of acute and chronic diseases, 
the implementation of HBOT as an adjunctive therapy still seems to be limited. This 
may be due to the fact that very few academic programmes at medical schools 
contain elements of hyperbaric medicine and most medical practitioners have little or 
no knowledge about HBOT or its practice.  Furthermore, because it has a high 
potential for monetary exploitation and unethical application, a high degree of 
medical skepticism has developed regarding its use [1, 2].  
Recognizing the need for an evidence-based approach to hyperbaric medicine 
practice, medical practitioners involved in hyperbaric medicine have conducted 
randomized trials to investigate the application of HBOT and a number of Cochrane 
reviews have subsequently been performed[3-21]. The extent to which this information 
is known by clinicians is however unknown. 
The primary investigator completed his postgraduate studies in hyperbaric medicine 
and is planning to open the first hyperbaric medical centre in the Kingdom of 
Bahrain.  It is however important to establish the level of knowledge of this type of 
therapy amongst colleagues who would have to refer patients in future, as well as 
their attitudes towards this kind of therapy.  This would identify possible knowledge 
gaps that could be addressed by means of continuous medical education events and 
provide valuable information regarding the future of this treatment modality within 
this setting. 
Literature review 
 
Definition and description of hyperbaric oxygen therapy 
 
“HBOT is a treatment modality in which a patient breathes 100% oxygen while inside 
a treatment chamber at a pressure higher than sea level pressure” (101 kPa or one 
atmosphere)[22, 23].  This then leads to specific therapeutic physiological effects.  
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Breathing 100% oxygen at one atmosphere (as commonly happens in many hospital 
situations) is not considered hyperbaric in nature or effect. 
The treatment can be provided in either a monoplace hyperbaric chamber (where the 
chamber is usually compressed with 100% oxygen), which can accommodate one 
patient. 
Figure 1: A monoplace hyperbaric chamber 
 
A multiplace hyperbaric chamber could accommodate more than one person.  Such 
a chamber is normally compressed with air and the oxygen is provided via an 
oxygen mask or head tent. 
Figure 2: A multiplace hyperbaric chamber 
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The history of hyperbaric oxygen therapy 
 
The alteration of atmospheric pressure in the treatment of certain medical conditions 
dates back more than 300 years.  In 1664 Henshaw advocated treating acute and 
chronic diseases of all kinds by the modification of atmospheric pressure[24].  The 
equipment used in this era (and the pressures at which the treatments were given) 
likely only had a placebo effect.   In the 1870s, a French surgeon named Fontaine 
converted an early chamber into the first hyperbaric operating room[25]. Several 
surgeons performed operations within hyperbaric chambers and reported favorable 
results[26]. 
 
Lorraine-Smith  recorded in 1899 that after providing 73% of oxygen at 101kPa of 
pressure, a fatal pneumonia developed in rats, thus reporting toxic effects of 
hyperbaric oxygen (HBO2) on the lungs[27]. In 1878 Paul Bert published a paper 
describing that breathing oxygen under pressure can cause a grand mal seizure and 
effect the central nervous system[27, 28].  HBOT in clinical medicine started with 
Churchill-Davidson and Boerema in 1955 and 1956[26, 29].  A growing concern in early 
1960’s by both hyperbaric and general physicians was that this treatment modality 
was being applied indiscriminately.  There was also a lack of scientific approach in 
the implementation of HBOT and a lack of a regulatory body.  Although HBO2 is 
used in the treatment of decompression sickness, there used to be a schism 
between diving medicine and hyperbaric medicine and it required a crisis of funding 
being revoked due to indiscriminate and unscientific use.  These concerns led to the 
establishment of a HBOT Committee, which produced its first critical work under 
Enrico Camporesi as editor – a critical appraisal of HBOT that became the template 
for the HBOT Committee Report of the Undersea Medical Society (UMS).  The 
committee became an internationally recognized authority on accepted indications 
for hyperbaric oxygen therapy. They regularly update and publish a list of accepted 
indications and discriminate between those conditions that are approved for 
treatment and those that are supported by sound scientific theory but are still 
requiring research. The UMS is now known as the UHMS (Undersea and Hyperbaric 
Medical Society). 
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The UHMS-approved indications for hyperbaric oxygen therapy 
The following indications (listed in Table 1) are approved uses of hyperbaric oxygen 
therapy as defined by the Hyperbaric Oxygen Therapy Committee[22].  
Table 1: The UHMS approved indications for hyperbaric oxygen therapy 
Table 1:  The UHMS-approved indications for hyperbaric oxygen therapy 
1 Air or gas embolism 
2 Carbon monoxide poisoning; cyanide poisoning 
3 Clostridial myostitis and myonecrosis (gas gangrene) 
4 Crush injuries, compartment syndromes and other acute traumatic 
peripheral ischaemias 
5 Decompression sickness 
6 Enhancement of healing in selected problem wounds 
7 Exceptional blood loss anaemia 
8 Intracranial abscess 
9 Necrotizing soft tissue infections 
10 Refractory osteomyelitis 
11 Skin flaps and grafts (compromised) 
12 Delayed radiation injury (soft tissue and bony necrosis) 
13 Thermal burns 
14 Acute retinal artery occlusion 
 
The indications listed on this table are all considered (after review of the literature 
and evidence) to have sufficient evidence of benefit and enough information is 
available to indicate a cost-benefit ratio that is favourable, meaning that a treatment 
regime that excludes HBOT would be more expensive that one which includes 
HBOT 
  
Indications recommended by the European Committee for 
Hyperbaric Medicine 
 
The European Committee for Hyperbaric Medicine (ECHM) evaluates the indications 
for inclusion in their list of “recommended indications” by means of conducting 
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consensus conferences, in which the indications to be recommended are agreed on 
by means of a consensus statement that is formulated[30].  This is done by means of 
having experienced clinicians (who are considered experts in their field) present 
opposing views regarding the use of hyperbaric oxygen for a specific indication and 
then drafting a consensus statement afterwards.  Table 2 (below) provides a list of 
indications recommended by the ECHM (with the levels of evidence presented)[30]. 
 
Table 2: The ECHM accepted indications for hyperbaric oxygen therapy 
Table 2: Accepted indications for HBO therapy (7th ECHM 
Consensus Conference, Lille 2004) 
Condition Accepted 
Level of Evidence* A B C 
Type I: Strongly Recommended (The jury considers the implementation of the 
recommendation of critical importance for final outcome of the patient/ quality of practice’/ future 
specific knowledge) 
CO Poisoning  X  
Crush syndromes  X  
Prevention of osteoradionecrosis after dental extraction  X  
Osteoradionecrosis of the mandible  X  
Soft tissue radionecrosis (cystitis)  X  
Decompression accidents   X 
Gas embolism   X 
Anaerobic or mixed bacterial anaerobic infections   X 
Type II: Recommended (The jury considers the implementation of the recommendation as 
positively affecting final outcome of the patient/ quality of practice/ future specific knowledge 
Diabetic foot lesions  X  
Compressed skin grafts and musculocutaneous flaps   X 
Osteoradionecrosis (other bones)   X 
Radio-induced proctitis or enteritis   X 
Radio-induced lesions of soft tissues   X 
Surgery and implant in irradiated tissue (prophylaxis)   X 
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Sudden deafness   X 
Ischaemic ulcers   X 
Refractory chronic osteomyelitis   X 
Neuroblastoma Stage IV   X 
Type III: Optional (The jury considers the implementation of the recommendation as an option) 
Post anoxic encephalopathy   X 
Larynx radionecrosis   X 
Radio-induced CNS lesions   X 
Post-vascular procedure reperfusion syndrome   X 
Limb re-implantation   X 
Burns > 20% of surface area and 2nd degree   X 
Acute ischemic ophthalmological disorders   X 
Selected non-healing wounds    X 
Pneumatosis cystoids intestinalis   X 
* The levels of evidence: 
A:   Recommendation supported by level 1 evidence (at least 2 concordant, large, double-blind, 
controlled, randomized studies with little or no methodological bias). 
B:   Recommendation supported by level 2 evidence (double-blind controlled, randomized studies 
but with methodological flaws; studies with only small samples, or only a single study). 
C:   Recommendation supported only by level 3 evidence (consensus opinion of experts). 
 
Description of the approved hyperbaric oxygen therapy indications  
Decompression sickness  
 
Decompression sickness (DCS) has many synonyms. These include Caisson's 
disease, the "bends," compressed air sickness, or diver's paralysis. DCS is a direct 
result of bubble formation within bodily tissues and the subsequent pathophysiologic 
changes induced by these bubbles. Although DCS may follow exposure to increased 
pressures, as in compressed gas or scuba diving, it can also follow rapid climbs in 
altitude or switches in breathing gas or the ambient (i.e. surrounding) gas medium 
during a hyperbaric exposure..  Because of its implications in operating jet aircraft 
and the space shuttle, DCS is a subject of research even in aerospace medicine[31-
33]
. DCS has been reported to occur in auxiliary medical personnel who accompany 
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and treat patients within multi-place chambers[34, 35].  After breathing compressed 
inert gases over a period of time, the partial pressures of the different gases reach 
new equilibriums within a person’s tissues (in accordance with Henry's Law).  In the 
case of nitrogen, for example, it is five times as soluble in fat as in air and becomes 
concentrated within fatty tissues, including the brain.  Unless adequate time is 
allowed during decompression for their elimination, the gases previously dissolved in 
solution or in tissues may form bubbles. Since oxygen is rapidly consumed and 
nitrogen is basically inert, these bubbles are mainly composed of nitrogen.  Because 
of the relatively poor circulation in fatty and cartilaginous tissues, a longer time is 
required for the elimination of gases from these tissues.  
 
Although reductions in ambient pressure in a ratio of 2:1 were tolerated in Haldane's 
experiments with goats to a maximum of 606 kPa, this ratio was later found to be 
optimistic[36, 37]. The true ratio is probably closer to 1.5:1[37]. That is, DCS is unlikely 
when ascending from example a pressure of 303 kPa to 202 kPa but DCS may be 
expected if one ascends from 303 kPa to 101 kPa. Therefore, DCS is rare in dives of 
less than 202 kPa or climbs of less than 5,550 meters in unpressurised aircraft.  It is 
possible to dive safely to depths greater than 202 kPa or to ascend to altitudes 
higher than 5,555 ft. To do so, however, requires a combination of ascent rates and 
pauses at certain depths or altitudes during ascent to allow excess inert gas to be 
eliminated before continuing decompression to the next level. In the case of 
compressed gas diving, this is called stage decompression. Decompression 
sickness can be prevented by adequate decompression times and performing 
decompression stops at appropriate depths for sufficient times, following different 
diving tables. It is important to realize that these diving tables (guidelines) are not 
completely safe and still have an associated decompression sickness incidence of 
between 1 and 5 percent[38]. 
 
Hyperbaric oxygen (“recompression therapy”) is recommended and approved for the 
treatment of DCS, based on the principle that it reduces the size of the bubbles 
which then move to smaller, more distal vessels. Recompression also hastens the 
dissolution and absorption of bubbles and eliminates inert gas more effectively by 
reducing the inspired inert gas partial pressure through the choice of therapeutic 
breathing gas - usually oxygen. Increased oxygen tensions help minimize ischemic 
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damage in the distal, hypoxic areas. In addition, by using 100% oxygen, nitrogen is 
removed from the bubbles and tissues at a faster rate (through counter diffusion). 
 
The standard treatment for DCS is referred to as the “long oxygen table”, in which 
the patient is recompressed to an initial depth of 18m and breathes HBO2 for 90 to 
150 minutes, after which the pressure is slowly reduced over 30 minutes to a 
treatment depth of 9m and HBO2 is provided for a further 150 to 300 minutes.  The 
pressure is then again reduced slowly over 30 minutes until the ambient atmospheric 
pressure is reached.  The oxygen is usually given for 25 minutes, followed by a 5 
minute air break in repeated fashion.  The total treatment usually lasts between 4 
hours and 45 minutes, but can last up to 8 hours and 10 minutes in severe cases.  If 
complete resolution of symptoms is not attained following the initial recompression, 
further recompression sessions could be provided (usually at a pressure of 240 kPa 
for 90 minutes) daily until no further improvement is symptoms is noted for two 
consecutive days. 
 
Carbon monoxide poisoning; cyanide poisoning 
 
Carbon monoxide (CO) poisoning is a complex event involving more than just the 
generation of carboxyhaemoglobin and the subsequent unavailability of haemoglobin 
to transport oxygen. CO is a systemic toxin capable of producing hypoxia at the 
cellular level in a number of ways. First, CO has an affinity for haemoglobin 
approximately 200 to 250 times greater than oxygen's[39]. Therefore, even in 
environments containing only small quantities of CO, haemoglobin rapidly binds CO 
and becomes unavailable for the transportation of oxygen. CO also binds to other 
haeme pigments such as myoglobin. Second, once bound to haemoglobin, CO 
adversely affects the oxygen-haemoglobin dissociation curve, shifting it to the left. 
Oxygen already combined with haemoglobin becomes more firmly attached and a 
tissue oxygen tension much lower than normal is required before the oxygen is 
released, thus leading to tissue hypoxia. Lastly, once in the mitochondria, CO binds 
to the cytochrome oxidase enzymes responsible for cellular respiration, especially 
cytochrome a,a3[40], the terminal enzyme in the electron transport chain.  This 
inhibits the final step in oxidative phosphorylation - the energy transfer from the 
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formation of metabolic water required for the production of ATP from ADP.  The end 
result is oxygen becomes less available to meet the cell's metabolic needs and death 
by cellular anoxia results with the release of cytochrome C and large amounts of 
reactive oxygen species as the terminal events.  . In fires there may be a complex 
mixture of fumes such as carbon monoxide, cyanide and other gases.  Cyanide 
inhaled in this combination with carbon monoxide and smoke inhalation is a 
recommended indication for hyperbaric oxygen therapy, since it could be fatal as a 
result of cytotoxic hypoxia, which leads to organ dysfunction and possibly death[41].  
Hyperbaric oxygen therapy is approved and recommended for the treatment of 
selected cases of CO poisoning, based on the theoretical principles of action and the 
fact that previous studies have excluded patients who would “obviously” benefit from 
this treatment modality (in these studies they have received HBO and were thus 
excluded from analysis).  There is still a lot of debate regarding the application of 
hyperbaric oxygen therapy in carbon monoxide poisoning[42, 43]. 
Recently a number of randomized controlled trials on hyperbaric oxygen therapy for 
carbon monoxide poisoning were reviewed and published in the Cochrane database 
in which the reviewer concluded that “there is no evidence that unselected use of 
hyperbaric oxygen therapy in the treatment of acute CO poisoning reduces the 
frequency of neurological symptoms at one month. The available evidence from 
randomized controlled trials is thus still insufficient to provide clear guidelines for 
practice.  Further research is needed to better define the role of hyperbaric oxygen 
therapy, if any, in the treatment of carbon monoxide poisoning. This research 
question is ideally suited to a multicentre, randomized, double-blind controlled 
trial”[44]. 
 
Air or gas embolism 
 
Arterial gas embolism is a major hazard of scuba diving ("diving air embolism"). Its 
exact incidence is hard to determine and many victims are probably recorded as 
drowning.  As a diver begins to ascend, the volume of gas within the lung expands 
(in accordance with Boyle's Law). If the glottis is closed and a diver surfaces too 
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quickly, as in a panic situation, the only escape for the expanding air mass is through 
the thin alveolar walls. Because alveolar rupture requires only a pressure gradient of 
approximately 11 kPa air embolism can follow breath holding ascents after taking a 
full breath at depth from as shallow as 111 kPa (a depth of approximately 1 metre) to 
the surface[45, 46]. Patients with localized areas of obstruction (asthma or secretions) 
are at risk to develop pulmonary over-distension even without breath holding. Air 
embolism is not restricted to divers.  It has been reported in a number of other 
traumatic and surgical conditions including blast injuries or penetrating trauma such 
as gun shot or stab wounds[47].  Gas may also enter the arterial circulation by 
shunting from the venous to the arterial systems.  Because 30% of the population 
have a probe patent foramen ovale, air sometimes can pass directly from the right to 
left heart; therefore, arterial gas embolism can follow either decompression sickness 
or medical procedures which permit gas entry into the venous circulation (iatrogenic 
air embolism is nearly 200 times as common as diving air embolism, with at least 
20,000 cases per year in the USA)[48].   
HBOT is approved and recommended for the treatment of air- or gas embolism 
based on the same principles as for DCS.  There are two HBO regimens that are 
commonly  used, depending on the facilities available: (1) either a brief period of 
compression in air or mixed gas at a depth equivalent to six times atmospheric 
pressure (606 kPa) followed by several hours in pure oxygen at 283kPa (e.g.: US 
Navy Treatment Table 6A), or (2) several hours compression in pure oxygen (e.g.: 
US Navy Treatment Table 6 or 9: at 283kPa or 253kPa respectively). Both 
approaches seem clinically comparable. 
 
Clostridial myostitis and myonecrosis (gas gangrene) 
 
Gas gangrene is one of the most dreaded complications associated with open 
wounds, but it may also occur spontaneously in the presence of malignancy and as a 
complication of surgery . Untreated, it invariably results in death within 48 hours of 
the onset of symptoms. Originally associated with contaminated war wounds, gas 
gangrene now has become almost exclusively a disease of the civilian population. 
Hart estimates there are 1,000 to 3,000 annual cases of gas gangrene in the United 
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States[49]. In a review of several published series, he found 49% of cases are 
posttraumatic, 35% postoperative, and 16% arise spontaneously[49, 50]. The treatment 
of gas gangrene and other anaerobic infections began in Amsterdam in 1960 and a 
subsequent case-series reported exceptional results[51].  In the year 2000, Korhonen  
published an article on HBO2 in acute necrotizing infections with special reference to 
the effects on tissue gas tensions, and showed that “HBOT resulted in a marked 
increase in tissue oxygenation in both healthy tissue and in the vicinity of infected 
tissue. The hyperoxygenated tissue zone surrounding the infected area may be of 
significance in preventing the extension of invading microorganisms[52].  HBO2 was 
also proven to inhibit alpha-toxin production, which has a direct link to patient 
morbidity and mortality[53-55].  
The UHMS Committee Report recommends HBO2 at 253 kPa every 8 hours for the 
first day and then reduced to twice daily treatments until improvement occurs and no 
further myonecrosis is evident. Of course, by itself HBO is useless - it must be 
combined with aggressive debridement and meticulous haemostasis to be of 
therapeutic value. Surgery should be delayed until after the first HBO treatment. This 
allows for the administration of antibiotics, treatment of electrolyte and fluid 
imbalances, provides better surgical demarcation of necrotic tissue, and makes the 
patient less toxic and decreases the surgical risk. 
 
Crush injuries, compartment syndromes and other acute traumatic peripheral 
ischaemias 
 
A “crush injury” is the direct result of an injury where there is tissue destruction by 
high energy transfer to the tissue and or interruption of blood vessels, resulting in a 
vicious spiral which causes ischemia, hypoxia, edema, disturbed microcirculation, 
and leads to secondary ischemia in the border area of the tissue affected by primary 
trauma.  There is thus usually a “gradient of injury” which contains the spectrum from 
dead (or necrotic) to living tissue of which the compromised (but not necrotic) 
component may vary significantly depending on the type of traumatic injury.  The 
latter can include other forms of trauma and even frost bite, burns and a number of 
non-mechanical traumas.  This is commonly complicated by stasis in the 
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microcirculation, reperfusion injury, and secondary infection, non-healing and non-
union all potentially resulting in delayed loss of tissue. Garcia, et al published an 
evidenced based approach for the use of hyperbaric oxygen therapy in the 
management of crush injuries and traumatic ischaemias[56].  They found that eight 
studies showed beneficial effects of hyperbaric oxygen therapy with only one 
reported major complication.  From these eight studies however, only one was a 
randomized, double-blinded placebo-controlled study[57], which indicated that 
hyperbaric oxygen therapy can be effectively applied for crush injuries.  
The recommended regimen for the treatment of crush injuries is 100% oxygen at 202 
kPa for 90 minutes, but it should be provided at 253 kPa if ischemia-reperfusion 
injury is present, and two 5 – 10 minute air breaks is required to reduce the risk of 
experiencing signs or symptoms of oxygen toxicity.  The first treatment should be 
provided within eight hours following the injury and should be given twice a day for 
the first three days.  
 
Enhancement of healing in selected problem wounds 
 
Many case reports and case-series demonstrate the beneficial effects of hyperbaric 
oxygen therapy in diabetic foot ulcers. The first controlled trial of hyperbaric oxygen 
therapy in lower extremity wounds was published nearly 30 years ago[58]. Since then 
there have been several prospective, randomized, controlled trials in non-healing 
diabetic foot ulcers[59-64]. Outcome measures in these clinical trials vary from one 
study to another. The systematic review of some of these trials provides evidence 
that, for patients with diabetic ulcers resistant to standard care, hyperbaric oxygen 
therapy decrease the risk of major amputation[19]. The findings that oxygen tensions 
around the ulcers are significantly raised following a course hyperbaric oxygen 
therapy supports a mechanism for this benefit.  Transcutaneous oximetry is used as 
part of the assessment of problem wounds and provides an objective basis for 
decision-making[65].   A Cochrane Review summarizes the evidence in RCT’s of 
hyperbaric oxygen therapy for chronic diabetic ulcers: “There is a strong case for 
further large randomized trials of high methodological rigour in order to define the 
true extent of benefit from administration of hyperbaric oxygen therapy”[66]. 
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Hyperbaric oxygen therapy also showed to be beneficial in treating patients with 
other non diabetic wound ulcers[67] , although arterial ulcers seem to respond poorly 
and HBOT for venous stasis ulcers is usually not cost-effective.        
Exceptional blood loss anaemia 
 
Anemia is defined as a reduction in the amount of haemoglobin or the red blood cells 
which carry it.  Anemia occurs whenever the haematopoietic equilibrium is disturbed 
by increased loss, reduced production or dysfunctional haemoglobin in red blood 
cells.  Anemia may result from a variety of causes. For example, it may be 
hereditary, as in sickle cell anaemia; it may be metabolic, as in folate deficiency; it 
may be aplastic, as in drug-induced; anaemia’s final common denominator is tissue 
hypoxia. Because the development of chronic anaemias allow sufficient time for the 
development of compensatory changes, affected individuals become capable of 
tolerating quite low haemoglobin levels. Because of religious convictions some 
patients (e.g. Jehovah's Witnesses) do not allow the transfusion of blood; in other 
cases, difficulties sometimes arise while attempting to successfully cross-match 
blood in a timely fashion.  Uncommon blood types and certain haemolytic anaemias 
could also benefit from HBOT.. Hart et al reported on the use of hyperbaric oxygen 
therapy in treating 26 patients, of which 22 were Jehovah's Witnesses[68]. They 
administered 202 kPa for 60 to 90 minutes until the patient's pulse decreased by 
one-third. They were removed from the chamber and closely observed until their 
pulse had nearly returned to pre-treatment levels. The process was then repeated. 
Initially treatments were needed every 3 to 4 hours, but after the first 24 hours the 
treatments could be spread out to every 8 to 12 hours. The total duration of 
hyperbaric oxygen therapy treatments depended on the severity of the blood loss as 
well as the patients underlying state. Hyperbaric oxygen therapy plays no role in the 
management of chronic anaemias.  
 
The treatment regimens provided today involves a very detailed approach, using 
pulmonary wedge pressures, calculation of the oxygen debt, providing intensive 
medical care and titrating hyperbaric oxygen therapy (to address calculated oxygen 
debt) in accordance with strict protocols[69]. 
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Intracranial abscesses 
 
Hyperbaric oxygen therapy is indicated as adjunctive therapy for intracranial 
abscesses in deep and dominant locations or in cases of multiple abscesses[70]. 
Although most infections are anaerobic, aerobic infections also respond to HBO.  It 
may also be used in situations where surgery is contraindicated and in patients 
showing no response to standard treatment. The development of perifocal edema 
around an intracranial abscess may progress to secondary hypoxic lesions in the 
surrounding brain tissues that can lead to a life-threatening situation and an increase 
in intra-cranial pressure.  The effects of hyperbaric oxygen therapy on perifocal brain 
edema and the increased intra-cranial pressure has been well documented over 40 
years ago in a series of studies performed by Miller et al[71-74].  It was found that  
hyperbaric oxygen caused a 30% reduction of intracranial pressure and a 19% 
reduction of cerebral blood flow in the absence of changes in arterial PCO2 or blood 
pressure, but only as long as administration of carbon dioxide caused an increase in 
both intracranial pressure and cerebral blood flow. When carbon dioxide failed to 
influence intracranial pressure or cerebral blood flow then hyperbaric oxygen had no 
effect.   
Lampl and Frey have reported on a number of cases treated with HBOT, with 
excellent results[75], leading to the inclusion of this indication to the UHMS and 
European list of indications.  They also report in the dramatic reduction in mortality 
with the use of hyperbaric oxygen (mortality reduced from 19.2% to 3.1%[75]. 
 
HBO2is administrated for intracranial abscesses at a pressure of 202 kPa to 253 kPa  
with a duration of 60-90 minutes per treatment and could be given twice per day 
depending on the condition of the patient.    
 
Compromised skin flaps and grafts  
 
Although hyperbaric oxygen therapy is not the first modality of treating routine 
complications of skin grafts, it is considered an appropriate adjunctive treatment 
modality in selected patients. In areas of impaired circulation, HBOT preserves 
tissue viability. Tissue oxygen tensions of 4-6 kPa (30 to 40 mmHg) are required for 
fibroblast regeneration and normal wound healing[65, 76]. Collagen deposition serves 
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as a matrix to support new blood vessel growth (neovascularization). New capillary 
buds start to be noticeable within 5 to 10 days of daily hyperbaric oxygen therapy 
and a rich vascular bed is established within one month[77].  In a compromised host 
or patient with marginal circulation, hyperbaric oxygen therapy will improve the 
granulation base and may permit "take" of a graft that would otherwise fail. HBOT is 
also useful in treating flaps which have a hypovascular base.  Using animals, HBO2 
has been demonstrated to preserve flap length compared to non-treated control 
animals[78]. HBOT may even have direct effects not dependent on the circulation. 
Using a pig model, Tan et al, raised skin flaps designed to become ischemic[79]. After 
killing the pigs, their carcasses were placed in a chamber. The flaps still responded 
and became pink! They conclude that, in the absence of circulation, this could only 
be explained by the flaps' direct absorption of oxygen from the chamber air. Li et al 
experimented on auricular composite grafts in rabbits treated with HBOT[80]. They 
suggest that HBOT enhanced graft survival, especially in the larger composite grafts.  
 
In compromised flaps the contributing factors include hypoxia, edema, arterial 
vasospasm, arterial or venous occlusion, congestion and dehiscence or infection. 
Another factor of major importance is the so-called “reperfusion injury syndrome” 
when re-establishment of circulation follows prolonged tissular hypoxia as in 
complicated free flaps. Patient health factors like age, smoking, systemic disease 
and/or relative therapy may interfere with the flap prognosis.  Clinical evaluation is of 
major importance and is tested according to the flap condition taking into account 
flaps characteristics like color, temperature, capillary fill and bleeding. The 
appearance of cyanotic colour in a graft is associated with delayed revascularization 
and hypoxia, white color with lack of blood supply and red color with presence of 
infection.  Follow up of the flap “take” is critical for the first 48 hrs.   Observation of 
the flap color may determine the leading factor of the complication. The primary 
cause of flap demise is not an inadequate arterial inflow but rather a venous 
insufficiency through a compromise venous outflow. 
 
If a surgical flap is clinically edematous, with a deep purple or dark blue colour, (i.e. 
in total venous occlusion), capillary refill is missing and the flap temperature is low, 
then HBO2 is recommended in the form of a twice-daily treatment at 202 kPa – 253 
kPa for 90–120 minutes, reducing to once-daily when the graft or flap has stabilized. 
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A utilization review is recommended after 20 treatments, whether preparing a site for 
grafting, or maximizing survival of a new graft. 
 
Necrotizing soft tissue infections 
 
Aggressive and often fatal, necrotizing soft tissue infections involve subcutaneous 
tissues, fascia and, occasionally, muscles. They are almost always polymicrobial, 
involving multiple strains of gram-positive and gram-negative organisms. These are 
often synergistic infections caused by mixtures of aerobes, facultative aerobes, and 
anaerobes (the aerobes consume oxygen resulting in a reduced environment in 
which anaerobes thrive). Infections usually arise in ischemic areas, such as those 
existing as a consequence of trauma, peripheral vascular disease, burns, 
malignancy, foreign body introduction, or operative wounds.  In addition, patients 
with altered host defence mechanisms, such as diabetics, are at increased risk. 
Endarteritis will occur, causing tissues to become hypoxic, hypovascular and 
hypocellular. Leukocytes may become sequestered in vessels, impairing local 
immunity, and incomplete substrate oxidation results in hydrogen and methane 
accumulation in the tissues. Tissue necrosis occurs, with purulent discharge and gas 
production, and reports of mortality range from 30% to 75%[81].  A review of the 
available literature was done by Jallali in 2005 and concluded that there were 
“encouraging results” when adding hyperbaric oxygen therapy as an adjunct to the 
standard treatment[82]. 
 
Conventional treatments may include surgical debridement with systemic antibiotics. 
In animal studies, hyperbaric oxygen therapy has a direct antibiotic effect, improving 
tissue oxygen tension, leukocyte function and bacterial clearance[83]. Integrin 
inhibition decreases leukocyte adherence, reducing systemic toxicity. Hyperbaric 
oxygen therapy has been reported to reduce mortality by up to two-thirds[84]. 
Hyperbaric oxygen therapy is particularly indicated in bacterial gangrene and non-
clostridial myonecrosis (which have high mortality and morbidity), and in 
compromised or unresponsive hosts[85].   
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The UHMS recommends twice-daily treatments for 90–120 min at 201–252 kPa, 
reduced to once daily when the patient's condition is stabilized[86].  Further 
treatments may be given to reduce relapse, and a utilization review is recommended 
after 30 treatments[86].  
 
Refractory osteomyelitis 
 
Osteomyelitis presents either with acute or chronic infection of bone and can be due 
to bacteria, mycobacteria, fungi, or (very rarely) viruses.  Chronic and unresponsive 
bone infections are mainly caused by bacteria, which may remain dormant for years. 
Combined with antibiotics, debridement and removal of foreign material, hyperbaric 
oxygen therapy is recommended in localized and diffuse osteomyelitis, particularly 
with vascular or immune compromise[87]. Hyperbaric oxygen therapy elevates  
plasma-based oxygenation and provides the level of hyperoxia required  for collagen 
synthesis and angiogenesis, increasing vascularity and oxygenation[40].  Leukocyte 
bacterial killing is enhanced , as is the efficiency  of certain antibiotics, by maximizing 
oxygen dependent aminoglycoside transport across bacterial cell walls[87] Hyperbaric 
oxygen therapy eliminates  anaerobes, promotes oxygen dependent osteoclastic 
resorption of infected bone[88]. Oedema, inflammation and pressure are significantly 
reduced.  Slack in 1965 was the first to use hyperbaric oxygen therapy in refractory 
osteomyelitis[89], controlled animal studies confirmed its efficiency[90, 91]. Davis et al 
reported the successful use of hyperbaric oxygen therapy in treating advanced 
malignant otitis externa, a progressive and potentially fatal form of refractory 
pseudomonal osteomyelitis of the ear canal and base of skull, usually affecting 
elderly diabetic patients[92].  
 
The severity of the disease forces the treatment regimen, but the UHMS 
recommends treatments generally for 90–120 min daily at 201 kPa – 252 kPa, in 
conjunction with debridement, antibiotics and nutritional support, and review is 
recommended after 40 treatments[87]. 
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Delayed radiation injury (soft tissue and bony necrosis) 
Radiation can induce a non-healing, hypoxic wound which may occur in either soft 
tissue or bone. The radiation damages the cellular and vascular components of 
tissues resulting in a proliferative endarteritis. This results in a hypoxic, hypocellular 
and hypovascular tissue.and a risk of non-healing following surgery[93]. Successful 
treatment with hyperbaric oxygen therapy is documented in post-radiation damage, 
including chest wall necrosis, radiation-induced haemorrhagic cystitis, and central 
nervous system radiation damage [94-96].  A recent trial, however, found little evidence 
for hyperbaric oxygen therapy in radiation-induced brachial plexopathy, though there 
were some improvements in warm sensory threshold and long-standing arm 
lymphoedema[96]. 
HBO2 increases vascular density and oxygenation in radiation-damaged tissue[97]. It 
also increases tissue angiogenesis which increases circulation to the injured area. 
This increases oxygenation resulting in better wound repair by stimulating collagen 
deposition. Marx has shown that tissue oxygen levels in irradiated areas approach 
80% of normal tissue levels within about approximately 20 hyperbaric oxygen 
therapy sessions. The benefits of HBOT are long lasting.  In one study, three year 
follow-up revealed pO2 levels that were still 80%-90% of those seen during the active 
treatment cycles which improved tissue oxygen gradients and angiogenesis and 
enhanced leukocyte bactericidal activity[98]. This facilitates healing and may enable 
grafts to be placed. Mainous, reported a case of excellent improvement in 
mandibular healing with HBO2 after radiotherapy[99]. Marx reported in 1985 that 
prophylactic HBOT before tooth extractions in heavily irradiated mandibles prevented 
mandibular osteoradionecrosis more effectively than penicillin[100]. HBOT given 
prophylactically prior to dental extraction is not 100% effective in preventing 
osteoradionecrosis. If given before dental extractions in high risk patients, 5% still 
develop osteoradionecrosis.  However, where radionecrosis developed it was of a 
minor nature and readily managed by simple surgery. Untreated radionecrosis 
resulted in severe radionecrosis requiring sequestrectomies and resections of the 
mandibula.  For comparisons sake, when only penicillin is given, 30% of patients 
develop osteoradionecrosis. Because it is much more economical to prevent 
osteoradionecrosis than to treat it, prophylactic HBOT is still recommended.  The 
term “prophylactic” is misleading, however. Tissue for which HBO is provided in a 
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previously irradiated area prior to surgery contains late radiation tissue damage. The 
HBO is applied to reverse the radiation tissue damage so that the tissue can 
withstand the increased metabolic requirements of healing following surgery. It is 
important to state that this is not prophylactic in the true sense of the word. It is 
indeed therapeutic. 
  
Neovius et al reported that patients with problem wounds following surgery and 
radiotherapy had complete healing after treatment with hyperbaric oxygen therapy 
and that hyperbaric oxygen therapy may reduce the incidence and progression of 
soft tissue radionecrosis, such as laryngeal radionecrosis[101], although there is less 
support for this in the literature than for osteoradionecrosis.  Marx showed that, in 
patients with previous radiation, “pre-operative hyperbaric oxygen therapy can 
reduce wound dehiscence and infections, and improve healing in soft tissue flaps, 
particularly in mandibular osteoradionecrosis, though randomized controlled trials 
are lacking”[97]. 
Hyperbaric oxygen treatment for mandibular osteoradionecrosis is recommended by 
the UHMS to consist of 30 daily 90-minute sessions at 241 kPa, with surgical 
debridement in more advanced disease[102].  Aitasalo et al proposed a lower number 
of treatments for cases that are treated early[103, 104]. 
 
Thermal burns 
The skin is the largest organ in the body and major burns to it result in multi-organ 
failure. Traditionally, the depth of a burn is classified as being either first, second or 
third degree. First degree burns, involving only the epidermis, are clinically 
manifested by localized erythema. Second degree burns extend into the underlying 
dermis and are marked by blisters, which often erode leaving behind red, moist and 
denuded skin. Because deeper elements of the dermis (the hair follicles and sweat 
glands) still contain epidermal tissue, second degree burns usually are capable of 
regenerating the epithelial layer, given enough time. Third degree burns are full 
thickness injuries in which the entire dermal layer of skin has been destroyed. These 
burns appear whitish and lack sensation. Re-epithelization is impossible and skin 
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grafts are needed to cover large areas. If a deep second degree burn becomes 
infected or desiccated, it can convert to a third degree burn. Initially, the greatest 
concerns in clinical management are hypovolaemia and the prevention of shock. 
Following a burn, initial vasoconstriction rapidly gives way to vasodilatation and 
stasis, the local capillaries become increasingly permeable, and plasma 
extravasates into the burned areas. A second concern in clinical management is the 
potential for infection. Most major burns are associated with a relative hypo immunity 
state, characterized by decreased levels of immunoglobulin and ineffective 
phagocytosis. Besides increasing local hypoxia, edema and changes in the 
microcirculation inhibit the ability of normal humeral and cellular immune elements 
from reaching the affected areas.  
There is evidence that HBOT reduces  polymorphonuclear  killing ability[105].  The 
hyperoxic environment results in vasoconstriction, decreases oedema, and 
increases collagen formation and angiogenesis. Phagocytic bacterial killing can be 
improved, and white cell endothelial adherence is inhibited, preventing capillary 
damage[106].  Hyperbaric oxygen therapy maintains the microvascular integrity, and 
reduces infection[107].  Hyperbaric oxygen therapy  also decreases the healing 
time[108], mortality and morbidity and hospitalization was reduced when compared to 
controls[109].  The need for grafting is likewise dramatically reduced [108, 110].  
However, other studies have showed no benefit from hyperbaric oxygen therapy in 
treating thermal burns[111]. Concerns that hyperbaric oxygen therapy could worsen 
pulmonary damage in thermal burns are still unproven.  
The UHMS recommends three sessions within 24 hours of injury and 90-minute 
treatments twice-daily thereafter, at 201 kPa – 241 kPa[109]. 
 
Mechanisms of action of HBO 
Hyperoxygenation  
 
Most oxygen (19.4 ml/dL) is carried in the blood being bound to haemoglobin when 
breathing air at atmospheric pressure.  A small amount of oxygen is carried in 
solution (in the plasma), and this portion will increase with an enlarged inspiratory 
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oxygen partial pressure due to Henry’s Law, which will in turn increase tissue 
oxygenation. When breathing normobaric air, arterial oxygen tension is 
approximately 13.3 kPa (100 mmHg), and tissue oxygen tension approximately 55 
kPa[65].  However, breathing 100% oxygen at a pressure of 304 kPa can increase 
arterial oxygen tensions to 267 kPa (2200 mmHg)[112, 113].  There is also a 
corresponding four-fold increase in the oxygen diffusion distance at the capillary 
arterial end and twofold increase at the venous end. This result in wound tissue 
oxygen tension increased up to 10 to 15 fold and a 68 ml/L of oxygen dissolved in 
plasma[114] (compared to 3 ml/L at atmospheric pressure breathing air), which is 
sufficient to support resting tissues without a contribution from haemoglobin[115].    
 
The physiological significance of dissolved oxygen (and the ability to increase the 
fraction of dissolved oxygen) is profound.  This is particularly true for respiration 
processes involved in wound healing, wound repair, processes involved in 
combating infections, nitric oxide functions, cytochrome P450 reactions, synthesis of 
neurotransmitters, etc. There is thus a physiological rationale for using HBO2 in 
many conditions and it should not be seen as merely a means of providing more 
oxygen substrate. HBOT also mobilizes stem/ progenitor cells from bone marrow[116]. 
All of these oxygen-dependent processes rely on the dissolved fraction of oxygen, 
since oxygen that is bound to hemoglobin is not available for any physiological 
processes.  Hemoglobin-bound oxygen must first dissociate from hemoglobin (and 
dissolve into the plasma) in accordance with the oxy-hemoglobin dissociation curve 
and then further diffuse (from the plasma) into the extravascular, extracellular space 
until eventually ending up in the intracellular space, where it can diffuse into the 
mitochondria and other organelles which would then utilize the oxygen molecules in 
biochemical processes.  Diffusion (and diffusion distance) is (amongst others, e.g. 
molecule size, type of tissues, membrane thickness, etc.) highly dependent upon the 
diffusion gradient that exists (diffusion takes place from a high gradient to a low 
gradient[117].  This results in the effects of hyperbaric oxygen therapy described in 
previous studies, namely that even poorly perfused wounds can receive oxygen via 
hyperoxygenated plasma[118]. 
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Table 3: Theoretical arterial oxygen tension and blood oxygen content for different treatment protocols: 
 Theoretical arterial oxygen tension and blood oxygen content for different treatment protocols 
Table 3:  Theoretical arterial oxygen tension and blood oxygen content for 
different treatment protocols 
Inhaled oxygen 
fraction 
Absolute pressure Arterial oxygen 
tension (mmHg) 
Oxygen dissolved 
in plasma (mL per 
dL of blood) 
0.21 101kPa (1 ATA) 100 0.31 
1.0 101kPa (1 ATA) 660 2.0 
1.0 202kPa (2 ATA) 1400 4.3 
1.0 303kPa (3 ATA) 2200 6.8 
 
Table 3 shows theoretical arterial oxygen tensions and the amount of oxygen 
dissolved in the blood for various hyperbaric therapy protocols as described by 
Thackham, et al[112].  
 
Stimulation of tissue growth and Angiogenesis 
 
Oxygen is essential for angiogenesis and new blood vessel formation in wounds. 
Vascular endothelial growth factor (VEGF) is the most specific growth factor for 
neovascularization. Continuous hypoxia inhibits neovascularization, intermittent 
hyperoxia stimulate angiogenesis by satisfying metabolic needs and by enhancing 
VEGF production, therefore, maintenance of adequate tissue oxygen tension is 
critical to wound healing[119, 120]. The process of angiogenesis requires approximately 
four weeks of hyperbaric oxygen therapy treatment sessions, but in essence reverse 
the micro-vasculopathic component of irradiated tissue or in the diabetic foot, 
resulting in steady increase in the tissue oxygen levels which is believed to be long-
lasting[121]. 
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Fibroblast proliferation and collagen deposition  
 
Fibroblasts are the major producers of collagen in the repair response. Collagen 
synthesis starts with hydroxylation of procollagen peptide chains by proline 
hydroxylase, one of the substrates for this process is molecular oxygen[122], 
procollagen then cleaved and cross-linked to form mature collagen fibrils. 
Hydroxylation of proline and deposition is crucially dependent on molecular oxygen, 
oxygen tension also influence collagen cross linking and wound mechanical 
strength[123]. 
 
Effects on microorganisms and host immune response 
 
Wounds represent a break in immunity to bacterial infections. The more hypoxic a 
wound, the more vulnerable it is. Polymorphonuclear (PMN) leukocytes engulf or 
phagocytose bacteria and expose them to reactive oxygen species (ROS). ROS 
react with several bacterial molecules such as DNA, proteins and carbohydrates. It 
also destroys membrane lipids of organisms in a lipid peroxydation process (chain 
reaction). This process is modulated by NADPH oxidase (nicotinamide adenine 
dinucleotide phosphate-oxidase) or phox which is a phagocytic oxidase, in this 
process large amounts of molecular oxygen is consumed, as much as fifty-fold the 
baseline value, in what is termed the “oxidative or respiratory burst”[124]. 
 
Antibiotic activity enhancement  
 
Oxygen tensions play an important role in the outcome of infections. Oxygen is cidal 
or static for microorganisms that lack defenses against oxidants.  In addition, 
hyperoxia potentiates (while anaerobiosis decreases) the activity of many 
antimicrobial agents. A series of studies have shown that increased tissue oxygen 
tensions reduce the minimum inhibitory concentrations and the minimum bactericidal 
concentration of E. Coli, Enterobacter, Klebsiella, and Staphylococcus against 
different aminoglycosides including: amikacin, gentamycin, and tobramycin[125, 126].   
Stellenbosch University   http://scholar.sun.ac.za
32 
Hyperbaric oxygen therapy, when combined with these antibiotics and surgery, is 
extremely useful as adjunctive therapy for treating tissue involving both anaerobic 
and aerobic bacteria in hypoxic wounds and tissues[127]. 
 
Vasoconstriction  
 
Exposure to oxygen at pressure results in a 20% reduction in blood flow in normal 
tissues (vasoconstriction). This effect is offset by the tenfold to fifteen fold increase in 
the oxygen content of plasma[128]. This vasoconstriction may favorably affect the 
neurogenic edema that is seen in the feet of diabetic patients. Hyperoxia probably 
does not cause vasoconstriction in ischemic or hypoxic tissues, specifically in 
diabetics, this is due to calcification with non-compressibility of their peripheral blood 
vessels and auto-sympathectomy effects[129]. 
 
Increased pressure and creation of gas gradients 
 
The increased pressure at which HBOT is provided results in a compression of gas-
spaces and a reduction in the volume of gases in accordance with Boyle’s law.  This 
effect is utilized in the treatment of decompression sickness and gas embolism.  
Breathing 100% oxygen during the treatment would also provide a gas gradient that 
is not only favourable for increasing oxygenation of tissues as described above, but 
also for the elimination of inert gases.  Again, this effect explains why it is used in the 
treatment of decompression sickness. 
 
Production of Nitric Oxide (NO) 
 
HBO2 induces the production of nitric oxide, which is known to be a key biological 
“messenger” and has a number of physiological effects.  A study by Thom et al 
showed that one of the effects of this is the mobilization of stem cells from the bone 
marrow[116]. 
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Safety and the side-effects of HBO therapy 
 
Hyperbaric oxygen therapy is considered to be a safe treatment modality if the 
necessary precautions are taken and patients are selected in accordance with the 
accepted international practice standards. The risks involved in the use of hyperbaric 
oxygen therapy are related to pressure changes and the toxic effects of oxygen.  
 
Pressure-related side effects 
 
Middle ear or sinus barotrauma  
In the presence of abnormalities, hyperbaric oxygen therapy may affect gas spaces 
where the pressure cannot be equalized, like the ears and sinuses. Middle ear 
equalization problems are experienced as pain or discomfort during compression. 
Middle ear barotrauma incidence is about 2% and the majority of problems can be 
resolved with simple means and minor invasive procedures and termination of 
hyperbaric oxygen therapy rarely becomes necessary[130]. Middle ear equalization 
problems usually are managed by slow decent rate, topical decongestants or 
insertion of tympanostomy tubes[130]. 
 
Pulmonary overpressure with pneumothorax  
 
Incidences of this side effect is very low in clinical practice; pulmonary barotrauma 
prevalence is reported to be 0.00045%[131]. Careful patient evaluation and clinical 
examination to rule out predisposing factors is mandatory in all candidates for 
hyperbaric oxygen therapy. 
 
Oxygen toxicity 
 
Pulmonary oxygen toxicity is only seen during extended periods of treatment and 
when a very high number of hyperbaric oxygen therapy treatment sessions are 
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provided.  Pulmonary oxygen toxicity from currently used wound-healing protocols is 
virtually unheard of[132]. 
 
Central nervous system toxicity may present with transient visual changes, hearing 
changes, nausea, tingling sensation or dizziness and can also lead to grand mal 
seizures[133]. Fever and certain medications can predispose one to this complication. 
Oxygen seizures are very rare, occurring 1 in 10,000 to 12,000 treatments[134-136]. 
They are self-limited and treated by providing air (instead of oxygen) to breath. 
Hyperbaric oxygen therapy may be reestablished after seizure activity has 
ceased[137]. These seizures are not associated with any long-term neurological 
damage, although repeated excessive exposures (not standard hyperbaric protocols) 
may lead to disturbed carbon dioxide transport, accumulation of carbon dioxide and 
neurogenic pulmonary oedema[138-140]. 
 
Reversible myopia 
 
An additional minor side effect is a transient change in visual acuity that usually 
revert to baseline within few weeks to months after treatment[141].  The rate of myopic 
change resulting from hyperbaric oxygen therapy has been reported to be 
approximately 0.25 diopter per week, with the changes being progressive during the 
period of the hyperbaric oxygen therapy[130, 141, 142].  The hyperoxic myopia is 
generally attributed to oxidative changes causing an increase in the refractive power 
of the lens. As mentioned, this change is temporary and reversal of the myopic shift 
after discontinuation of the hyperbaric oxygen therapy normally takes place within 3 
to 6 weeks[130, 142]. 
 
Irreversible cataracts 
 
There is no evidence that current protocols predispose to cataract formation[142, 143].  
The growth of preexisting nuclear cataracts may be stimulated by prolonged 
sessions of hyperbaric oxygen therapy, and new cataracts were found since patients 
who were exposed to high number of hyperbaric oxygen therapy treatments (>150 
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treatments). The nuclear cataracts were not reversible after such a high number of 
sessions[142]. 
Previous similar studies on the subject 
 
A number of previous studies have evaluated the knowledge and attitudes of health 
practitioners regarding the use of hyperbaric oxygen therapy and the incorporation 
thereof in their practice[144-146]. Another survey is reported to evaluate the attitude of 
maxillofacial fellows regarding their attitudes regarding the performance of a national 
trial for hyperbaric oxygen therapy in radionecrosis of the jaw[147].  These studies 
were all conducted on a targeted group of practitioners (e.g. wound care 
practitioners and maxillofacial fellows). The authors found that most respondents 
were unaware of the method of delivery of hyperbaric oxygen therapy and generally 
had a poor knowledge of the physical and physiological effects.  Despite the 
relatively poor knowledge found in all these studies, the authors also report that most 
respondents had a positive attitude towards the use of hyperbaric oxygen therapy in 
their practice.  Very few respondents have previously referred patients for hyperbaric 
oxygen therapy and on a national level it seems like those who have referred 
patients for hyperbaric oxygen therapy are clustered together (most likely in the 
vicinity of a hyperbaric facility).  Younger respondents and those who had previously 
referred patients for HBOT were more likely to have a positive attitude towards the 
use of hyperbaric oxygen therapy. 
No study regarding the use of hyperbaric oxygen therapy has ever been conducted 
in the Kingdom of Bahrain and there has indeed been no similar study published to 
describe the knowledge and attitudes of practitioners within any of the Middle 
Eastern countries. 
Study aim and objectives 
 
The main aim of this study is to assess the characteristics of medical practitioners, 
their working knowledge of and attitudes toward hyperbaric oxygen therapy within 
the Royal Medical Services of the Kingdom of Bahrain. 
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The following secondary objectives were also investigated during this study: 
1. Estimating the proportion of practitioners with knowledge of internationally 
recommended and approved indications for hyperbaric oxygen therapy 
2. Observing how many specialists know the indications for hyperbaric oxygen 
therapy within their field of specialization. 
3. Evaluating whether medical practitioners have an understanding of the 
physiological principles explaining the effects of hyperbaric oxygen therapy 
4. Evaluating the perception of hyperbaric oxygen therapy in medical and 
surgical specialties.   
Methodology 
Review by Health Research Ethics Committees 
 
The study protocol was submitted for review by the Health Research Ethics 
Committee of the University of Stellenbosch and was approved on 14 July 2011, with 
reference number: N11/06/179.  The Ethics Approval letter is attached as Addendum 
1. 
The protocol was also submitted for review by the Research Committee of the Royal 
Medical Services of the Kingdom of Bahrain, with approval received on 27 June 
2011.  The letter of approval is attached as Addendum 2.  
 
Study design 
 
A combined quantitative and qualitative cross-sectional study was performed to 
reach the aims and objectives of this study, using a research questionnaire and semi 
structured interview. 
 
Study Setting 
 
The study took place between 03 August 2011 and 05 October 2011 at the Royal 
Medical Services in The Kingdom of Bahrain including all the departments within the 
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military hospital and Sh. Mohammed Bin Khalifa Cardiac center, as well as all 
military camp clinics that fall under the Royal Medical Services.   
 
There are approximately 300 medical practitioners who work in the royal medical 
services.  Many of the practitioners are Bahraini citizens and there are also 
physicians employed from all over the world such as South Africa, India, Canada, 
United States of America, Pakistan, and others. 
 
The Bahraini physicians typically completed their undergraduate medical training in 
the UK, Ireland, Bahrain, Kingdom of Saudi Arabia, and other European Countries. 
Most performed their postgraduate studies at North American universities (in Canada 
and the USA), while others studied in Germany and the UK and a few studied in 
South Africa.  The non-Bahraini Physicians typically completed their undergraduate 
and postgraduate training in their native countries. 
 
The Kingdom of Bahrain is a previous British colony, with English and Arabic as the 
main official languages used in the military and the Royal Medical Services.  All 
medical practitioners are fluent in the English language.  All the research instruments 
were provided in English only. 
 
Study participants 
 
A list of names of all the medical practitioners employed by the Royal Medical 
Services was obtained from the Human Resources Department.   Each clinical 
department was visited and appointments were set up for completion of the 
questionnaires and conducting of the interviews.  The military and civilian medical 
practitioners working in these departments were invited to take part in this study, 
provided that the inclusion and exclusion criteria were met.   
 
Inclusion criteria 
 
Potential participants were required to meet all the following criteria to be eligible to 
take part in the study. 
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• Be qualified medical practitioners  
• Formally employed by the royal medical services  
• Must be willing to give informed consent 
 
Exclusion criteria 
 
Potential participants presenting with any one of the following were not eligible for 
inclusion in the study: 
• Persons not willing to provide informed consent 
• Questionnaires that were illegible  
• Medical practitioners who have undergone specialized training in hyperbaric 
or diving medicine. 
• Medical practitioners who were on military deployments or on leave for 
duration beyond the study period. 
 
Sampling methods and sample size 
 
The sampling frame consisted of all the military and civilian medical practitioners in 
the Royal Medical Services.  In order to properly evaluate the information, no sample 
was taken for the purpose of the written questionnaire.  
 
For the purposes of the semi-structured interview, a purposive sample was taken to 
ensure representivity across the different departments.  No sample size was 
determined for this part of the research project prior to initiation of the study and 
sampling continued until data saturation occurred. 
 
Data sources and data collection 
 
The primary investigator developed a questionnaire (see Addendum 3), with the 
assistance of his supervisor, which aimed to provide the details required to meet the 
aim and objectives of the study.  Informed consent was obtained from all participants 
before they were requested to complete the questionnaire in a private and 
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confidential setting provided by the Royal Medical Services, which ensured that the 
process was not rushed and that participants had enough time to complete the 
questionnaire. The informed consent document is attached as Addendum 4.   
 
A second informed consent document (see Addendum 5) was completed for each 
candidate participating in the semi-structured interview.  The data was collected by 
means of a digital voice recording of the semi-structured interview, conducted by the 
primary investigator in accordance with pre-set question guidelines (see Addendum 
6).  These interviews also took place in a private and confidential setting provided by 
the Royal Medical Services.   
 
Data management and statistical analysis 
 
The findings of the survey were captured and stored in a Microsoft Excel 
spreadsheet.  The data was analysed by means of 2x2 contingency tables and the 
associations were tested using the chi-squared test (with alpha=0.05) or the Fisher’s 
Exact test if individual cell frequency assumptions were not met.  Odds ratios (with 
95% confidence intervals) were used to evaluate possible factors associated with 
different levels of knowledge. 
 
The transcriptions of the interviews were analysed to establish common themes, 
which was relatively easy, since the questions asked of participants already provided 
a thematic approach.  The findings of the interviews are presented separately.  
Typical responses to the questions are quoted verbatim below. 
 
Ethical aspects 
 
The research protocol was approved by the Health Research Ethics Committee of 
Stellenbosch University, as well as the research committee of the Bahrain Defence 
Force Royal Medical Services.  All participants were required to provide informed 
consent prior to participation in the study and separate consent was required for the 
qualitative component of the study. 
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Survey component results 
Study participants 
 
A total of 302 medical practitioners are working for the Royal Medical Services of the 
Kingdom of Bahrain.  103 of these practitioners were not available for participation in 
the study (being deployed, on leave, on sick leave, etc.).  Three medical practitioners 
were not eligible for inclusion due to previous specialized training in diving or 
hyperbaric medicine (including the primary investigator).  Of the 196 being available 
for participation, 103 would not provide informed consent.  A total of 93 medical 
practitioners participated in the research project.  No questionnaires were illegible 
and all of them were included in the analysis.   
 
Figure 1 provides the flow-diagram of the sampling frame, selection process and 
final sample obtained. 
 
 
 
 
 
 
 
 
 
 
 
302 possible 
participants 
65 on leave or deployed 
38 in training 
3 with specialised training 
196 available for 
participation 
103 refused consent 
 
93 included 
Figure 3: Flow-diagram of study participants 
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Descriptive data 
 
A total of 93 medical practitioners, with a mean age of 38.8 (SD = 8.7) years, were 
included in the survey component of the study.  Of all the participants in the survey, 
77.4% were appointed as civilians within the Royal Medical Services, while 22.6% 
had appointments as military officers and 63.4% were registered as Bahraini 
nationals, while 36.6% were registered as international medical practitioners.  The 
median year in which all participants obtained their primary medical degree was 
1996 (range: 1974 – 2011) and for specialists this was 2004 (range: 1980 – 2011).   
 
All departments, except Obstetrics & Gynaecology and Paediatrics were represented 
in the study.  The average time that the medical practitioners had been employed in 
the specific department was 8.4 (SD = 7.8) years.  Figure 4 indicates the frequency 
by which each department was represented in the survey questionnaire. 
 
 
Figure 4: 
Figure 4: Bar chart of the frequency by which each clinical department was represented in the survey 
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The survey participants were representative of all the levels of seniority within the 
hospital, with a smaller proportion of chief residents participating.  The number of 
participants at a specific level of appointment is displayed in Figure 5. 
 
Figure 5  
Figure 5: Bar chart of the number of participants at a specific level of appointment 
 
 
 
Knowledge of hyperbaric oxygen therapy 
 
Participants who had never heard about hyperbaric oxygen therapy before 
comprised 11.8%.  Of the 85 participants (88.2%) who had heard about this 
treatment modality before, 28 (32.9%) first heard about hyperbaric oxygen therapy 
during their undergraduate studies and 28 (32.9%) during their postgraduate studies.  
The rest of these participants had read about hyperbaric oxygen therapy in journal 
articles, textbooks or heard about this treatment modality during discussions with 
colleagues.  The majority of these participants had not heard about hyperbaric 
oxygen therapy or read about it in a journal article in the previous calendar year 
(28.6% of those who previously had heard or read about hyperbaric oxygen therapy 
before indicated that they had heard or read about it more than 5 years ago). 
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When all the indications listed by an individual participant is considered, 82.8% 
(n=77) could correctly name only one indication.  The most commonly cited 
indications were “problematic wounds” (n=43) and “decompression sickness” (n=39).  
72% (n=67) could mention two indications; 53% (n=50), 39% (n=37), 25.8% (n=24), 
20.4% (n=19), 15% (n=14) and 9.7% (n=9) could mention 3, 4, 5, 6, 7 and more than 
seven indications respectively.  One person was able to mention all 14 indications 
listed by the UHMS and ECHM. 
 
Figure 6 indicates the number of times a specific indication (as listed by the UHMS 
or ECHM) was mentioned by the study participants, as well as the number of times 
the participants indicated whether (although they knew that this was an indication for 
hyperbaric oxygen therapy) they considered such an indication as falling outside of 
their area of practice  or specialisation (in blue) or within their area of specialisation 
(in red). 
Figure 6: Bar chart of the number of times a specific indication for hyperbaric oxygen therapy was 
mentioned by participants 
 
 
Stellenbosch University   http://scholar.sun.ac.za
44 
 
The percentages of practitioners who mentioned a specific indication for hyperbaric 
oxygen therapy, who also considered the specific indication to be within his or her 
discipline or area of speciality, is captured in Figure 7.  The percentages were 
calculated by dividing the number of persons considering the indication to be within 
their area of speciality by the total number of persons who mentioned the condition 
to be an indication for hyperbaric oxygen therapy. 
 
Figure 7: Bar chart of the percentage of participants mentioning a specific indication who also considers 
the indication to fall within their specialty 
 
 
 
Knowledge of contra-indications 
 
Thirty-six of the participants correctly mentioned a pneumothorax as a contra-
indication for hyperbaric oxygen therapy.  “Pregnancy” and “Chronic Obstructive 
Pulmonary Disease” (or emphysema) was cited by 16 and 12 participants 
respectively as contra-indications, while respiratory infections, claustrophobia, drugs 
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and barotrauma were cited less frequently.  Table 4 provides the frequency by which 
contra-indications were cited. 
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Table 4: Frequency table of contra-indications cited by study participants 
Table 4: Frequency table of contra-indications 
                 cited by study participants 
Absolute contra-indications correctly identified 
Pneumothorax 36 
Relative contra-indications correctly identified 
Pregnancy 16 
COPD/ Emphysema 12 
Respiratory infections 10 
Claustrophobia 7 
Fever 6 
Medication 5 
Barotrauma 5 
Asthma 3 
Chemotherapy 3 
Malignancy 3 
Chest surgery 2 
Pulmonary Fibrosis 1 
Oxygen toxicity 1 
Unstable patient 1 
Incorrectly cited "contra-indications" 
Glaucoma 1 
Hypertension 1 
Pulmonary embolism 1 
Seizures 1 
TM Perforation 1 
Vessel injuries 1 
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Factors associated with knowledge of hyperbaric oxygen therapy 
 
 
A good knowledge of hyperbaric oxygen therapy was defined by the primary 
investigator as being able to correctly mention more that seven of the indications 
listed by the UHMS and ECHM.  Analyses were performed to see whether any factor 
is associated with such knowledge.  Table 5 indicates the odds ratios (OR), with 95% 
confidence intervals (CI) and the p-values associated with participants knowing more 
than seven indications for hyperbaric oxygen therapy 
 
Table 5: Factors associated with knowledge of more than 7 indications for hyperbaric oxygen therapy 
Table 5:  Factors associated with knowledge of more than 7 indications for HBO 
 OR 95% CI p-value 
Year of qualification after 1995  1 0.23 – 4.3 0.287 
Year of specialist qualification after 1995  1.4 0.12 – 15.16 0.427 
Age >40 0.98 0.25 – 3.93 0.27 
Employment as a civilian medical practitioner 1.02 0.19 – 5.34 0.322 
Registration as Bahraini vs. International  2.15 0.42 – 11.01 0.199 
Specialists vs non-specialists 1.02 0.25 – 4.05 0.274 
Heard of HBO during undergraduate training 2 0.49 – 8.09 0.176 
Heard of HBO during postgraduate training 0.85 0.20 – 3.66 0.280 
Read about HBO in journal articles 2.5 0.56 – 11.2 0.155 
 
 
 
Lickert scale responses 
 
The Lickert scale responses, testing participants’ attitudes towards hyperbaric 
oxygen therapy yielded interesting results.  Seventy five participants (80.6%) agreed 
(or strongly agreed) that they felt that they knew very little about hyperbaric oxygen 
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therapy.  Despite this, 69.9% (n=65) still indicated that they would recommend 
hyperbaric oxygen therapy for their patients (although 75 participants, or 80.6%, 
indicated that they have never referred any of their patients for hyperbaric oxygen 
therapy.  Most participants (n=78; 83.9%) indicated that they would like to receive 
more information on hyperbaric oxygen therapy.  The participants indicated that 
hyperbaric oxygen therapy is expensive (n=65), but also that it is cost-effective 
(n=71) and that it is valid as a treatment modality (n=77).  The frequency of a specific 
response to the Lickert scale statements (indicating whether the participant strongly 
agrees, agrees, disagrees or strongly disagrees with the statement) are depicted in 
Figure 8. 
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Figure 8: The frequency of participant responses to the Lickert scale statements 
Figure 8: Bar chart indicating the participants’ responses to the Lickert scale statements 
Bar chart indicating the number of participant responses to the 
Lickert Scale questions
0 10 20 30 40 50 60 70
I have seen a hyperbaric chamber before
HBOT is a valid treatment modality
HBOT is expensive
HBOT is not cost-effective
I have previously referred a patient for HBOT
The kingdom of Bahrain has chambers for HBOT
There are a number of hyperbaric chambers in the Gulf countries
I feel I know very little about the clinical application of HBOT
I would like to receive more information on HBOT
I would recommend HBOTto my patients
Number of responses 
Strongly disagree Disagree Agree Strongly agree
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Semi-structured interview component results 
Study participants 
 
Participants involved in the semi-structured interview component of the study came 
from the same sampling frame as the participants completing the questionnaire.  At 
the time of completion of the questionnaires, potential candidates were invited to 
participate in the interview component of the study, which was also conducted 
between August and October 2011.  A purposive sample was taken to ensure a 
degree of representivity across the different disciplines. 
 
Thirteen participants were interviewed, representing the Surgical, Ear-, Nose and 
Throat, Medical, Ophthalmology and Primary Health Care Departments.  No 
participants from the Obstetrics and Gynaecology or the Paediatric departments 
were willing to participate in this component of the study. 
 
Findings 
 
Because the interview took place in a semi-structured manner, the specific themes to 
be investigated were already pre-selected.  The following qualitative information was 
obtained from the participants: 
 
Participants’ knowledge of hyperbaric oxygen therapy indications within their 
field of work 
 
Some of the specialist medical practitioners have previously been confronted with 
HBOT as a treatment modality, while some interviewees indicated that they have 
insufficient knowledge about HBOT and were not able to list specific indications for 
HBOT. Even some of the participants who were able to mention specific indications 
for HBOT (also within their speciality) were not able to explain or mention the 
physiological mechanisms of action of HBOT, neither how HBOT would interact to 
Stellenbosch University   http://scholar.sun.ac.za
51 
address the pathophysiological mechanisms of the disease or how HBOT should be 
applied as an adjunctive treatment.   
   
“My information or my knowledge … is very small, so I cannot say 
or add more than these things, but I hope that it can be here or 
something that has been given for the doctors that’s to… or some 
knowledge, so we can also help our patients or explain more 
specific for the patient that this thing can help in treatment” 
 
Those who had previous knowledge about hyperbaric oxygen therapy, felt that it was 
a good treatment modality, some indicating that they had patients who went for 
treatment abroad (especially in Europe).  These patients would return with 
information on hyperbaric oxygen therapy and for some practitioners this was a 
source of information regarding the use of hyperbaric oxygen therapy.  This was 
most commonly mentioned for diabetic foot lesions. 
 
“Many patients need this hyperbaric oxygen therapy concerned 
with patients with diabetic foot” 
 
Knowledge regarding the mechanisms of action of hyperbaric oxygen therapy 
 
The majority of the participants had no knowledge of the mechanisms of action of 
hyperbaric oxygen therapy and the majority responded to the question “Do you know 
the mechanisms of action of hyperbaric oxygen therapy” with a simple “no”.   
 
Knowledge regarding the levels of evidence existing for hyperbaric oxygen 
therapy 
 
A surprisingly large number of participants have read about the use of hyperbaric 
oxygen therapy in journal articles and in textbooks.  However, the general knowledge 
of the existing literature supporting the use of hyperbaric oxygen therapy as 
adjunctive treatment modality was quite low. 
 
Stellenbosch University   http://scholar.sun.ac.za
52 
“I,…I have read this in some of the studies and articles regarding this therapy 
and the amazing part of it – even from the first session, the patient could 
experience a change in his vision, which is really a promising result.” 
 
“there is some research and research works have been done before and it 
gives evidence of the process of healing and improvement of the patients 
exposed to this hyperbaric oxygen” 
 
“Yes, I read some articles about this type of medicine as well as in 
postgraduate internal medicine books” 
 
Referral of patients and including hyperbaric oxygen therapy in their practice 
 
A limited number of practitioners have referred patients for hyperbaric oxygen 
therapy.  The main reason given for not referring a patient for hyperbaric oxygen 
therapy (and thus the main barrier mentioned by the participants to implementing 
hyperbaric oxygen therapy as part of their clinical practice) was the lack of 
availability of the chambers and equipment. 
 
“We don’t have…, actually, in Bahrain we don’t have a chamber” 
 
“Of course, we need actually a chamber – it is very important – 
especially in our speciality…” 
 
“Actually it has not happened before, because I think that these 
machines are not available at our hospital…” 
 
“I think the main barrier is the availability of these hyperbaric 
chambers” 
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Discussion 
 
Study participants 
 
A relatively small proportion of the possible number of participants in the sampling 
frame (93 of a possible 302) was included in the study.  
 
A large number of potential participants (n=103) refused to participate.  Specific 
reasons for their refusal to participate were not captured as part of this study, but 
informal discussions implicated a high workload (with insufficient time to participate) 
as a contributing factor.  Another reason specifically mentioned by non-participants 
was a lack of knowledge regarding hyperbaric oxygen therapy and their perceived 
inability to contribute to the research.  Others indicated that they do not want to 
participate because they felt that hyperbaric oxygen therapy did not have a place 
within their practice of medicine.  This was specifically experienced within the 
paediatrics and Obstetrics & Gynaecology departments.  The fact that these persons 
did not participate in the study may have biased the results of the study and explain 
why specific associations were not found to be statistically significant. 
 
Non-participation for other reasons would likely result in less bias.  Sixty-five 
participants were on leave or deployed during the time of the study, which 
unfortunately took place during a period in which the Kingdom of Bahrain suffered 
civil unrest, which resulted in a large number of the Royal Medical Services’ medical 
practitioners being deployed around the country for months at a time.  After the 
conflicts subsided, these practitioners took leave upon their return to their home 
bases.  This further reduced the number of participants available for participation.  
Thirty-eight of the medical practitioners were enrolled for studies abroad and were 
also not available for participation.  Another factor that influenced the availability of 
participants is the fact that the survey was conducted over the holy month of 
Ramadan, during which many medical practitioners were on leave.  As mentioned, 
these factors are likely to only have a minor effect on the results, since military 
deployments, the taking of leave and religious background would not affect the 
outcomes investigated and would thus unlikely bias or confound the results. 
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Of the ninety-three medical practitioners participating in the survey, 77.4% were 
civilian and only 22.6% had a military appointment.   This ratio shows only a minor 
difference from the ratio of persons appointed by the military health services (which 
is approximately 60% civilian).  This is again most likely due to the fact that the 
military medical practitioners were required to assist during military deployments in 
the country, work in the military camps or be part of external military training 
exercises in support of the larger Royal Medical Services programme.   The 
professional registrations of the medical practitioners (63.4% Bahraini and 36.6% 
with international registration), is representative of the registrations of medical 
practitioners in the Royal Medical Services. 
 
No persons working within the department of Obstetrics and Gynaecology or the 
department of Paediatrics were willing to participate in the study.  Practitioners within 
these specialities did not see a place for hyperbaric oxygen therapy within their field 
of practice.  However, previous studies have indicated that carbon monoxide 
poisoning during pregnancy and in children may have devastating effects[148].  
Although there is some controversy in the literature[44], the mechanisms of action 
underpinning the use of hyperbaric oxygen therapy in carbon monoxide poisoning 
would clearly favour the use of hyperbaric oxygen therapy within their fields.  It 
should furthermore be noted that paediatric patients and pregnancy have been 
specific exclusion factors in studies examining the effect of hyperbaric oxygen 
therapy in carbon monoxide poisoning[44], which means that an opinion cannot yet be 
formulated regarding this indication.  Other indications that are approved by the 
Undersea and Hyperbaric Medical Society[22] and/ or recommended by the European 
Committee for Hyperbaric Medicine[30], for which adequate evidence exists, could 
also affect patients seen within these departments, e.g. crush injuries, necrotising 
infections, selected problem wounds, etc.  However, since medical practitioners from 
other departments would also be involved in the treatment and management of these 
patients, the effect of these practitioners’ non-participation is not likely to have a 
major effect on patient care, although it may have provided valuable information 
regarding the knowledge and attitudes of these medical practitioners. 
 
Participants in the survey represented all levels of seniority.  Even consultants and 
heads of department participated in the survey.  This adds significant strength to the 
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study, since these senior personnel members are in decision-making positions and 
their knowledge and attitudes are likely to affect junior colleagues.  Unfortunately not 
many senior residents participated in the survey.  This is most likely due to their high 
workload (compared to other practitioners in the same department).   
Participant knowledge of hyperbaric oxygen therapy 
 
When considering the fact that there are (broadly speaking) 14 indications that are 
collectively approved by the Undersea and Hyperbaric Medical Society and the 
European Committee for Hyperbaric Medicine, the percentage of medical 
practitioners having a clear knowledge of the indications for this treatment modality is 
very low.  Of the medical practitioners participating in the survey, 11.8% have never 
heard about hyperbaric oxygen therapy before.  Most people were able to mention at 
least one indication, but this is to be expected in a military setting, where there is 
some knowledge regarding the treatment of decompression sickness in military 
divers.  The fact that “selected problem wounds” were mentioned with a very high 
frequency is surprising.  This was most commonly cited as “diabetic wounds” (and 
coded as “selected problem wounds” by the primary investigator, which is a very 
encouraging prospect, since there is some evidence that hyperbaric oxygen therapy 
is effective for selected patients with diabetic wounds[19, 60, 63, 64] and Bahrain also has 
a very high prevalence of diabetes[149, 150].  The one person who was able to mention 
all 14 indications for hyperbaric oxygen therapy has never received specialised 
training in hyperbaric medicine, but he has worked in a hospital (in Singapore) during 
his postgraduate training in which he had access to a hyperbaric facility and used to 
regularly refer patients for treatment. 
 
The lack of availability of hyperbaric facilities in the Middle East and the fact that 
hyperbaric oxygen therapy as a treatment modality is not specifically included in 
most undergraduate and postgraduate training programmes would explain the very 
low level of knowledge about this treatment modality. These facts were confirmed 
during the structured interview component of this study and is consistent with other 
similar surveys performed[146, 151]. 
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Despite the lack of availability of treatment facilities, a high percentage of 
practitioners indicated that there had been some reference to the use of hyperbaric 
oxygen therapy in their undergraduate or postgraduate training.  It was interesting to 
find a large number of participants (n=14) mentioning that they first heard about 
hyperbaric oxygen therapy in discussions with a colleague.  Unfortunately most 
participants have not had any interaction with a hyperbaric medicine practitioner and 
they have not heard or read about it for at least the past five years. 
 
Medical practitioners who participated in the survey displayed some knowledge of 
the hyperbaric oxygen therapy approved indications within their speciality, which is 
encouraging. The number of indications mentioned by individuals was also 
encouraging, but specifically also pointing to the effect of military training (where 
medical practitioners are exposed to military divers and associated decompression 
sickness and its treatment with hyperbaric oxygen therapy).  Information about 
hyperbaric oxygen treatment was also likely obtained through specific training events 
and continued medical education that consists of lectures, books, journals or specific 
postgraduate training that the Royal Medical Services provide to the medical 
practitioners in their employ.  
 
Even the rarely used and highly specific indications were mentioned by some 
medical practitioners participating in the survey, which is indicative of a high level of 
knowledge in some individuals.  In the structured interview it became clear that some 
practitioners have previously worked in hospital settings where hyperbaric oxygen 
therapy was available as an adjunctive treatment.    
  
A large number of participants in the survey were able to correctly mention the 
absolute and relative contra-indications for hyperbaric oxygen therapy.  There were 
however a number of “contra-indications” mentioned that would not bar a person 
from treatment and which may in fact make the provision of hyperbaric oxygen 
therapy easier (e.g. perforation of the tympanic membranes). 
 
A number of factors were identified to be associated with a high level of knowledge 
of the indications for hyperbaric oxygen therapy (defined as correctly mentioning 
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more than 7 of the approved indications).  Participants who were able to mention 
more than seven indications were more likely to: 
• have specialised after 1995  
• hold a Bahraini medical registration rather than an international registration 
• have heard about hyperbaric oxygen therapy during their undergraduate 
education. This could be explained by the fact that postgraduate studies are 
generally quite focussed on the specific medical field and it is thus unlikely 
that a broad, general approach to the use of various indications for hyperbaric 
oxygen therapy would be used.  Postgraduate studies would thus likely be 
limited to indications specific to the area of speciality. 
• have read about hyperbaric oxygen therapy in journal articles (likely indicative 
of continuing medical education). 
None of these associations found during the study were statistically significant and 
these results should thus be interpreted with caution. 
 
“Problematic wounds” mentioned as an indication for hyperbaric oxygen therapy was 
also the indication which most practitioners (who cited the indication) felt as falling 
within their area of specialisation.   
 
Lickert scale responses  
   
The Lickert scale data indicates that a large proportion (37.6%) of the participants 
have seen a hyperbaric chamber before and these participants were more likely to 
be employed as a military officer (Odds Ratio = 4.48; 95% CI = 1.6 – 12.7; Chi2 = 
0.003).  This is to be expected, since they would be exposed to military divers and 
pilots as part of their work and have access to chambers as part of their military 
training. 
 
Although a high proportion of participants felt that proving hyperbaric oxygen therapy 
is considered an expensive treatment modality, most still consider it to be cost-
effective despite the expense and considered it to be a valid treatment modality.  
This is in line with economic studies performed on the application for hyperbaric 
oxygen therapy for a number of indications.  An economical analysis by the 
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Canadian Agency for Drugs and Technologies in Health reviewing the use of 
adjunctive hyperbaric oxygen therapy for diabetic foot ulcers has come to the 
conclusion that hyperbaric oxygen therapy is more effective than standard care 
alone and reduces major lower extremity amputation rate from 32% to 11% with a 
decrease in the proportion of unhealed wounds and an acceptable 12 year cost 
outcome (19% reduction in overall health care costs) compared to standard care[152]. 
Likewise, according to European data, the risk for major surgery and disability is 
considered 15 times higher in diabetics versus non-diabetics and increases with age 
or a history of previous amputation. Contra-lateral amputations are necessary in 50% 
of cases within 4 years of the initial intervention and ipsilateral re-amputations in 
about 27%. The use of adjunctive hyperbaric oxygen therapy can reduce the 
incidence of major surgery up to 82% as well as general morbidity, length of 
hospitalization and cost as demonstrated in the table 6 below[153].  
Table 6: Mortality, morbidity, hospital stay and cost of HBO versus non-HBO in diabetic patients 
Table 6: Mortality, Morbidity, Hospital stay and cost of HBO versus non-HBO 
in diabetic patients 
 Mortality Morbidity Hospital 
stay 
HBO cost Total cost 
HBO ---% 5% 60 days € 3000 € 36000 
Non-HBO 31% 30% 100 days  € 55000 
Potential 
saving/pt 
    € 19000/pt 
Potential saving 
% 
    35% 
 
An economical evaluation on demographic data of the Italian Ministry of Health on 
diabetic foot ulcers and diabetic foot lesions at risk for amputation, indicate a 
potential annual saving for the National Health Care system ranging between 58 and 
69 million €, if hyperbaric oxygen therapy would be included as a standard adjunct in 
the treatment of the diabetic foot[154].  It is not known to which extent this information, 
as well as data from other studies is known by the participants and it is possible that 
their perception of the cost-effectiveness of hyperbaric oxygen therapy for these 
indications is not based on the above facts. 
 
All of the “UHMS-approved” indications for hyperbaric oxygen therapy are approved 
on specific criteria, one of which is the requirement for the hyperbaric oxygen should 
be cost-effective[22].  In our study there was a strong association between 
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participants feeling that hyperbaric oxygen therapy is expensive and those feeling 
that it is cost-effective (Odds Ratio = 5.2), but this was not statistically significant 
(95% CI = 0.6 – 44.4; Fisher’s exact = 0.069). 
Referral of patients 
 
Only 13.98% of participants indicated that they have previously referred a patient for 
hyperbaric oxygen therapy. It was quite surprising to see that practitioners who have 
not previously referred patients for hyperbaric oxygen therapy had no association 
with their agreement (or not) whether HBOT is “a valid treatment modality” 
(p=0.2111).  Again, military participants were much more likely to have previously 
referred a patient for hyperbaric oxygen therapy than civilian participants (Odds 
Ratio = 7.6; 95%CI = 2.1 – 27.1; p=00016) and they were much less likely to feel that 
they have insufficient knowledge about hyperbaric oxygen therapy (Odds Ratio = 
0.09; 95% CI = 0.02 – 0.3; p<0.0001).  The perceived lack of availability of chambers 
within Bahrain (and other Middle Eastern countries) seems to be a major barrier to 
referral of patients, since patients would have to travel to Europe or elsewhere for 
therapy.  A high percentage of practitioners indicated that they would refer their 
patients for hyperbaric oxygen therapy. 
Conclusion 
 
Although this study was restricted in terms of availability of personnel (due to civil 
unrest and religious commitments), some encouraging findings were elicited.  There 
was a positive disposition toward the use of HBOT and there is also a good 
opportunity for knowledge intervention, since many practitioners indicated that they 
would like more information about HBOT. Similar to what has been found in previous 
studies, this study confirmed that medical practitioners generally have a poor level of 
knowledge of the indications for hyperbaric oxygen therapy, its mechanisms of 
action, as well as its side-effects and contra-indications.  A visit to a hyperbaric 
facility and discussion of case-studies would likely have a positive impact on using 
adjunctive hyperbaric oxygen therapy in practice. 
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Addendum 3: The research questionnaire 
The knowledge of medical practitioners in the Bahrain Defence Force about 
the clinical application of hyperbaric oxygen therapy 
1.  In which department are you currently working?  
 
2.  How long have you been working in this discipline?  months OR 
 
  years 
 
3.  Which position do you currently hold in this department?   Intern 
 
    Resident 
 
    Senior resident 
 
    Chief resident 
 
    Consultant 
 
    Head of Department 
 
4.  State the year in which you have received your undergraduate medical degree  
 
5.  If you are a specialist, in which year did you qualify (as a specialist)?  
 
6.  What is your current age?  years  
 
7.  What is your current employment status in the BDF?  Military medical practitioner 
 
    Civilian medical practitioner 
 
8.  Which of the following describes your current registration best? 
 
  Registered Bahraini medical practitioner 
 
  International medical registration – working on contract with the BDF 
 
9.  Have you ever heard about the application of “hyperbaric medicine” before?  Yes  No 
 
 9.1.  If “yes”, please indicate where you first heard about hyperbaric medicine 
 
  Undergraduate school   
 
  Postgraduate school   
 
  From colleagues   
 
  From patients/ friends   
 
  From books/ journals   
 
  Other (specify):  
 
 9.2.  If you have read a book/ journal on hyperbaric medicine before, please 
indicate whether you are read it: 
 
  In the last month 9.3.  Book/ journal name: 
 
  In the last year  
 
  In the last 5 years  
 
  Longer than 5 years ago  
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10.  Please list the internationally accepted indications for hyperbaric oxygen therapy you are aware 
of: 
 
 a.   
   
 b.   
    
 c.   
   
 d.   
   
 e.   
   
 f.   
   
 g.   
   
 h.   
   
 i.   
   
 j.   
   
 k.   
   
 
11.  Please indicate in the boxes on the right (above) which indications you consider to be within 
your field of speciality. 
 
12.  List the contra-indications for hyperbaric oxygen therapy you are aware of 
 
  
 
  
 
  
 
13.  Please complete the following table by indicating how you currently feel about the statements 
made. 
 Strongly 
agree 
agree disagree 
Strongly 
disagree 
 
a. I have seen a hyperbaric chamber before     
 
b. Hyperbaric oxygen therapy is a valid treatment 
modality 
    
 
c. Hyperbaric oxygen therapy is expensive      
 
d. Hyperbaric oxygen therapy is not cost-effective     
 
e. I have previously referred a patient for hyperbaric 
oxygen therapy 
    
 
f. The kingdom of Bahrain has chambers for hyperbaric 
oxygen therapy 
    
 
g. There are a number of hyperbaric oxygen therapy 
chambers in the Gulf countries 
    
 
h. I feel I know very little about the clinical application of 
hyperbaric oxygen therapy 
    
 
i.  I would like to receive more information on hyperbaric 
oxygen therapy (e.g. lectures) 
    
 
j. I would recommend hyperbaric oxygen therapy to my 
patients 
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Addendum 4:  Informed consent document for the research 
questionnaire 
 
PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
TITLE OF THE RESEARCH PROJECT: 
Survey for the knowledge of the military and civilian medical practitioners in 
the Royal Medical Service in the kingdom of Bahrain with regards to the clinical 
application of hyperbaric oxygen therapy 
 
REFERENCE NUMBER: N11/06/179 
PRINCIPAL INVESTIGATOR: Dr ADEL ABDUL AAL 
ADDRESS: 
Royal Medical Services Hospital 
Wali Al Ahed Highway 
P. O. Box - 28743 , West Riffa 
Kingdom of Bahrain. 
Tel: (+973) 17766666 / 17766233 
www.bdfmedical.org  
 
CONTACT NUMBER: (+973) 39909993 
You are being invited to take part in a research project.  Please take some time 
to read the information presented here, which will explain the details of this 
project.  Please ask the study staff or doctor any questions about any part of 
this project that you do not fully understand.  It is very important that you are 
fully satisfied that you clearly understand what this research entails and how 
you could be involved.  Also, your participation is entirely voluntary and you 
are free to decline to participate.  If you say no, this will not affect you 
negatively in any way whatsoever.  You are also free to withdraw from the 
study at any point, even if you do agree to take part. 
This study has been approved by the Health Research Ethics Committee at 
Stellenbosch University and will be conducted according to the ethical 
guidelines and principles of the international Declaration of Helsinki, South 
African Guidelines for Good Clinical Practice and the Medical Research Council 
(MRC) Ethical Guidelines for Research. 
And Also This study has been approved by the Health Research Ethics 
Committee at the Royal Medical Services Hospital-Bahrain Defence Force and 
will be conducted according to the ethical guidelines and principles of the 
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international Declaration of Helsinki, the Royal Medical Services Hospital 
Guidelines for Good Clinical Practice and the Research Ethics Committee (REC). 
 
What is this research study all about? 
 The study will take place at the Royal Medical Services in The Kingdom of 
Bahrain.  It will include all the departments within the military hospital 
and Sh. Mohammed Bin Khalifa Cardiac centre, as well as all military 
camp clinics that fall under the medical services. 
 We are looking for all medical practitioners in the Royal Medical Services  
to be part of this study 
 In this study we want to evaluate the knowledge of medical practitioners 
regarding hyperbaric oxygen therapy. 
 If you agree to be part of this study, you will need to complete a 
questionnaire that will indicate your knowledge regarding the 
application of hyperbaric oxygen therapy in clinical practice. 
 All the questionnaires are coded and no personal information will be 
written on it to ensure total confidentiality.  
Why have you been invited to participate? 
 You are a medical practitioner at the Royal Medical Services.  In this 
study we want to evaluate the knowledge of medical practitioners in the 
Royal Medical Services regarding hyperbaric oxygen therapy.   
What will your responsibilities be? 
 If you agree to be part of this study, you will need to complete a 
questionnaire.  This will take approximately 15 – 20 minutes. 
Will you benefit from taking part in this research? 
 You will not directly benefit from taking part in this study 
Are there in risks involved in your taking part in this research? 
 There is no risk for you while participating in this study. This study has no 
interventions – you only need to complete a questionnaire anonymously. 
 
If you do not agree to take part, what alternatives do you have? 
 If you do not want to be part of this study, you will NOT be affected in 
any way.  Your participation is totally voluntary. You can withdraw from 
the study at any time.  However, after you have returned your 
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questionnaire, we will not be able to identify your questionnaire and 
you can thus not withdraw from the study at that time. 
 
Who will have access to your questionnaire? 
Only the primary investigator and the study supervisor will have access to the 
questionnaires.  No personal information is available on the questionnaires and 
it is not possible to determine who has completed the questionnaires. 
Will you be paid to take part in this study and are there any costs 
involved? 
 
 No, you will not be paid to take part in the study. 
 There will be no costs involved for you, if you do take part. 
 
Is there any thing else that you should know or do? 
 You can contact Dr Adel Abdul Aal at tel (+973)39909993 if you have any 
further queries or encounter any problems. 
 You can contact the Health Research Ethics Committee in South Africa at 
+27-21-938 9207 or the Ethics Committee in Bahrain at (+973) 17 
766945 if you have any concerns or complaints that have not been 
adequately addressed by the study personnel. 
 You will receive a copy of this information and consent form for your 
own records. 
 
Declaration by participant 
 
By signing below, I …………………………………..…………. agree to take part in a 
research study entitled (Survey for the Knowledge of the Military and Civilian 
Medical Practitioners in the Royal Medical Service in the Kingdom of Bahrain 
with regards to the Clinical Application of Hyperbaric Oxygen Therapy ). 
I declare that: 
• I have read or had read to me this information and consent form and 
it is written in a language with which I am fluent and comfortable. 
• I have had a chance to ask questions and all my questions have been 
adequately answered. 
• I understand that taking part in this study is voluntary and I have not 
been pressurised to take part. 
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• I may choose to leave the study before handing in the questionnaire 
and will not be penalised or prejudiced in any way. 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2011. 
 
........................................................... ........................................................  
Signature of participant Signature of witness 
 
Declaration by investigator 
 
I (name) ……………………………………………..………..……………………declare that: 
 
• I explained the information in this document to 
………………………………….. 
• I encouraged him/her to ask questions and took adequate time to 
answer them. 
• I am satisfied that he/she adequately understands all aspects of the 
research, as discussed above 
• I did not use a interpreter.  
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2011. 
 
 
........................................................... ........................................................  
Signature of investigator Signature of witness 
 
Stellenbosch University   http://scholar.sun.ac.za
81 
Addendum 5:  Informed consent document for the structured interview 
 
PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
 
TITLE OF THE RESEARCH PROJECT: 
Survey of the knowledge of the military and civilian medical practitioners in the 
Royal Medical Service in the kingdom of Bahrain with regards to the clinical 
application of hyperbaric oxygen therapy 
 
REFERENCE NUMBER: N11/06/179 
PRINCIPAL INVESTIGATOR: Dr ADEL ABDUL AAL 
ADDRESS: 
Royal Medical Services Hospital 
Wali Al Ahed Highway 
P. O. Box - 28743 , West Riffa 
Kingdom of Bahrain. 
Tel: (+973) 17766666 / 17766233 
www.bdfmedical.org  
 
CONTACT NUMBER: (+973) 39909993 
You are being invited to take part in a research project.  Please take some time 
to read the information presented here, which will explain the details of this 
project.  Please ask the study staff or doctor any questions about any part of 
this project that you do not fully understand.  It is very important that you are 
fully satisfied that you clearly understand what this research entails and how 
you could be involved.  Also, your participation is entirely voluntary and you 
are free to decline to participate.  If you say no, this will not affect you 
negatively in any way whatsoever.  You are also free to withdraw from the 
study at any point, even if you initially agree to take part. 
This study has been approved by the Health Research Ethics Committee at 
Stellenbosch University in South Africa and will be conducted according to the 
ethical guidelines and principles of the international Declaration of Helsinki, 
South African Guidelines for Good Clinical Practice and the Medical Research 
Council (MRC) Ethical Guidelines for Research. 
And Also This study has been approved by the Health Research Ethics 
Committee at the Royal Medical Services Hospital-Bahrain Defence Force and 
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will be conducted according to the ethical guidelines and principles of the 
international Declaration of Helsinki, the Royal Medical Services Hospital 
Guidelines for Good Clinical Practice and the Research Ethics Committee (REC). 
 
What is this research study all about? 
 The study will take place at the Royal Medical Services in The kingdom of 
Bahrain in which it will include all the departments within the military 
hospital and Sh. Mohammed Bin Salman Cardiac center, also all-military 
camp clinics that fall under the medical services. 
 We are looking for all medical practitioners in the Royal Medical Services 
to be part of this study 
 In this study we want to evaluate the knowledge, experience and 
attitudes of the medical practitioners in Bahraini Royal Medical Services 
regarding hyperbaric oxygen therapy. 
 The first part of the project involved the completion of a research 
questionnaire, but you are invited to take part in the second part of the 
research project, namely a semi-structured interview. This means that 
you will be asked a number of questions regarding the application of 
hyperbaric oxygen therapy. 
 The interview will last for approximately 15 minutes. 
 All the interviews will be recorded, so that your answers could be 
captured correctly.  The interviews will be typed afterwards and your 
personal information will not be available in this format.  
Why have you been invited to participate? 
 You are a medical practitioner at the Royal Medical Services. In this study 
we want to evaluate the knowledge and attitudes of the medical 
practitioners in the Royal Medical services about hyperbaric oxygen 
therapy.   
What will your responsibilities be? 
 If you agree to be part of this study, you will be asked a number of 
questions regarding the use of hyperbaric oxygen therapy. You only have 
to answer these questions truthfully. 
 You should not inform other colleagues about the content of the the 
semi-stractured interview until such time as this study has been 
completed. 
Will you benefit from taking part in this research? 
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 You will not benefit directly from taking part in this study.  Your answers 
will however inform us of how practitioners feel about hyperbaric oxygen 
therapy. 
Are there in risks involved in your taking part in this research? 
 There is no risk for you while participating in this study. No interventions 
are tested – you only have to answer questions during an interview.  The 
study is conducted totally anonymously. 
If you do not agree to take part, what alternatives do you have? 
 If you do not want to be part of this study, you will NOT affect you in any 
way. This study is totally voluntary.  You can withdraw from the study 
even if you initially agreed to take part 
 
Who will have access to your semi-structured interview answers? 
Only the primary investigator (who will conduct the interview) will know who 
have answered the questions.  The interview will be typed afterwards and the 
digital files will be erased after it has been typed.  These typed interviews 
(which contain no identifying information) will be stored in a secure cabinet for 
a period of 5 years, after which it will be destroyed.  No person will thus know 
who has provided the answers to the questions during the interview. 
 
Will you be paid to take part in this study and are there any costs 
involved? 
 
 No, you will not be paid to take part in the study. 
 There will be no costs involved for you, if you do decide to take part. 
 
Is there any thing else that you should know or do? 
 You can contact Dr Adel Abdul Aal at tel (+973)39909993 if you have any 
further queries or encounter any problems. 
 You can contact the Health Research Ethics Committee in South Africa at 
+27-21-938 9207 or the Ethics Committee in Bahrain at (+973) 17 
766945 if you have any concerns or complaints that have not been 
adequately addressed by the study personnel. 
 You will receive a copy of this information and consent form for your 
own records. 
 
Declaration by participant 
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By signing below, I …………………………………..…………. agree to take part in this 
semi- structured interview about the research study entitled (Survey for the 
Knowledge of the Military and Civilian Medical Practitioners in the Royal 
Medical Service in the Kingdom of Bahrain with regards to the Clinical 
Application of Hyperbaric Oxygen Therapy). 
 
I declare that: 
• I have read or had read to me this information and consent form and 
it is written in a language with which I am fluent and comfortable. 
• I have had a chance to ask questions and all my questions have been 
adequately answered. 
• I understand that taking part in this study is voluntary and I have not 
been pressurised to take part. 
• I may choose to leave the study at any time and will not be penalised 
or prejudiced in any way. 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2011. 
 
 
........................................................... ........................................................  
Signature of participant Signature of witness 
 
Declaration by investigator 
 
I (name) ……………………………………………..………..……………………declare that: 
 
• I explained the information in this document to 
………………………………….. 
• I encouraged him/her to ask questions and took adequate time to 
answer them. 
• I am satisfied that he/she adequately understands all aspects of the 
research, as discussed above 
Stellenbosch University   http://scholar.sun.ac.za
85 
• I did not use an interpreter. 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2011. 
 
 
........................................................... ........................................................  
Signature of investigator Signature of witness 
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Addendum 6:  Structured interview guidelines 
 
Semi-structured interview  
Thank you for agreeing to participate in this study on Hyperbaric Oxygen 
Therapy.  This component of the study consists of a few questions we want 
you to answer truthfully.  There are no “right” or “wrong” answers! 
 
1- Do you know of specific indication(s) for the use of hyperbaric oxygen 
therapy within your specialty? (Specify) 
 
2- (For these indications) Do you know the mechanism(s) of action or the 
“underlying physiological explanation” why HBO is used for  these 
indications? (specify) 
 
3- Do you give us an idea of the evidence that exists for these indications?  
 
4- Have you ever referred patients for hyperbaric oxygen therapy?  
a. If yes – give us more information 
b. If no – any specific reason? 
 
5- Have you read any journal article or a book on hyperbaric oxygen 
therapy? (give details: when last, which publication, etc.) 
 
6- What do you consider to be the barriers (if any) to including hyperbaric 
oxygen therapy in your practice? 
 
7- Which actions/ processes would promote the inclusion of hyperbaric 
oxygen therapy in your practice? 
 
8- Do you have any specific opinion on hyperbaric oxygen therapy or 
anything else you would like to add? 
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